131 related articles for article (PubMed ID: 6117586)
1. Peptide challenges in affective illness.
Cohen RM; Cohen MR
J Clin Psychopharmacol; 1981 Jul; 1(4):214-22. PubMed ID: 6117586
[TBL] [Abstract][Full Text] [Related]
2. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine effects of carbamazepine in patients with affective illness.
Joffe RT; Post RM; Ballenger JC; Rebar R; Gold PW
Epilepsia; 1986; 27(2):156-60. PubMed ID: 3082622
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological challenge strategies: implications for neurochemical mechanisms in affective disorders and treatment approaches.
Risch SC; Kalin NH; Murphy DL
J Clin Psychopharmacol; 1981 Jul; 1(4):238-43. PubMed ID: 6117587
[No Abstract] [Full Text] [Related]
5. Neuropeptides as novel antidepressants.
Prange AJ; Loosen PT
Mod Probl Pharmacopsychiatry; 1982; 18():164-77. PubMed ID: 6124881
[No Abstract] [Full Text] [Related]
6. Luteinizing hormone responses to luteinizing hormone releasing hormone (LHRH) in acute mania and the effects of lithium on LHRH and thyrotrophin releasing hormone tests in volunteers.
Hunter R; Christie JE; Whalley LJ; Bennie J; Carroll S; Dick H; Goodwin GM; Wilson H; Fink G
Psychol Med; 1989 Feb; 19(1):69-77. PubMed ID: 2498919
[TBL] [Abstract][Full Text] [Related]
7. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone.
Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Iranmanesh A; Veldhuis JD; Bouillon R
Clin Endocrinol (Oxf); 2002 May; 56(5):655-69. PubMed ID: 12030918
[TBL] [Abstract][Full Text] [Related]
8. The effect of LHRH and TRH on human interferon-gamma production in vivo and in vitro.
Grasso G; Massai L; De Leo V; Muscettola M
Life Sci; 1998; 62(22):2005-14. PubMed ID: 9627099
[TBL] [Abstract][Full Text] [Related]
9. The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones.
Looij BJ; Nieuwenhuijzen Kruseman AC; Mudde AH; Frölich M; Piaditis GP; Hodgkinson SC; McLean C; Grossman A; Coy DH; Rees LH
Clin Endocrinol (Oxf); 1986 Feb; 24(2):149-56. PubMed ID: 2871949
[TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression.
Frye MA; Dunn RT; Gary KA; Kimbrell TA; Callahan AM; Luckenbaugh DA; Corá-Locatelli G; Vanderham E; Winokur A; Post RM
Biol Psychiatry; 1999 Apr; 45(8):1049-52. PubMed ID: 10386189
[TBL] [Abstract][Full Text] [Related]
11. Clinical investigations for emotional effects of neuropeptide hormones.
Ehrensing RH; Kastin AJ
Pharmacol Biochem Behav; 1976; 5(Suppl 1):89-93. PubMed ID: 13418
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide therapies in chronic schizophrenia: TRH and vasopressin administration.
Brambilla F; Aguglia E; Massironi R; Maggioni M; Grillo W; Castiglioni R; Catalano M; Drago F
Neuropsychobiology; 1986; 15(3-4):114-21. PubMed ID: 3097570
[TBL] [Abstract][Full Text] [Related]
13. Neurologically active peptides.
Barbeau A; Gonce M; Kastin AJ
Pharmacol Biochem Behav; 1976; 5(Suppl 1):159-63. PubMed ID: 13415
[TBL] [Abstract][Full Text] [Related]
14. Serial DST, TRH test, and TRH-like immunoreactivity measurements in major affective disorders.
Itoh N; Matsui N; Fuwano S; Yaginuma H; Miyashita O; Sakai M
Biol Psychiatry; 1987 May; 22(5):559-72. PubMed ID: 3107620
[TBL] [Abstract][Full Text] [Related]
15. Different effects of pyridostigmine on the thyrotropin response to thyrotropin-releasing hormone in endogenous depression and subclinical thyrotoxicosis.
Coiro V; Volpi R; Marchesi C; DeFerri A; Capretti L; Caffarri G; Colla R; Chiodera P
Metabolism; 1998 Jan; 47(1):50-3. PubMed ID: 9440477
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine abnormalities in affective disorders.
Extein I; Pottash AL; Gold MS
Encephale; 1982; 8(2):203-11. PubMed ID: 6809445
[TBL] [Abstract][Full Text] [Related]
17. The thyroid-stimulating hormone response to thyrotropin-releasing hormone in mania and bipolar depression.
Extein I; Pottash AL; Gold MS; Cadet J; Sweeney DR; Davies RK; Martin DM
Psychiatry Res; 1980 May; 2(2):199-204. PubMed ID: 6774358
[TBL] [Abstract][Full Text] [Related]
18. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
Oki S; Nakao K; Tanaka I; Horii K; Nakai Y; Shimbo S; Watanabe M; Nakane T; Kuwayama A; Kageyama N; Imura H
J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
[TBL] [Abstract][Full Text] [Related]
19. The TRH-stimulation test in DSM-III personality disorder.
Kavoussi RJ; Coccaro EF; Klar H; Lesser J; Siever LJ
Biol Psychiatry; 1993 Aug; 34(4):234-9. PubMed ID: 8399820
[TBL] [Abstract][Full Text] [Related]
20. Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH.
Jeppsson S; Nilsson KO; Rannevik G; Wide L
Acta Endocrinol (Copenh); 1976 Jun; 82(2):246-53. PubMed ID: 818858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
